Analyst Expectations for Denali Therapeutics's Future
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish and somewhat bullish ratings for Denali Therapeutics (NASDAQ:DNLI) in the last quarter. The average price target for the stock is $81.12, a significant increase from the previous average of $53.50. The current price of Denali Therapeutics is $23.1.
August 31, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have a bullish outlook on Denali Therapeutics, with an average price target significantly higher than the current price. This could potentially drive the stock price up in the short term.
The bullish ratings and significantly higher average price target indicate that analysts expect the company's stock price to increase. This positive sentiment could influence investors and drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100